Gastrointestinal Tumor Research and Treatment
Gastrointestinal Tumor Research and Treatment is a research topic within Gastroenterology. Science Explorer counts 32k research works in it since 1950. 10.2% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the diagnosis and treatment of gastrointestinal stromal tumors (GISTs), including the efficacy and safety of targeted therapies like Imatinib Mesylate and Sunitinib, the role of PDGFRA and KIT mutations in GISTs, consensus approaches for management, surgical considerations, prognostic factors, use of EUS-guided fine needle aspiration, and the significance of succinate dehydrogenase (SDH) deficiency. It also explores the use of PET imaging for response evaluation.
- Imatinib Mesylate
- Sunitinib
- PDGFRA Mutations
- KIT Mutations
- GIST Consensus Conference
- Surgical Management
- Prognostic Factors
- EUS-guided Fine Needle Aspiration
- SDH Deficiency
- PET Imaging
- Research works
- 32k fractional, since 1950
- In the world top 10%
- 3.3k per year above
- Top-10% rate
- 10.2% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +14% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Gastrointestinal Tumor Research and Treatment research?
By volume, China and the United States publish the most (1.3k and 1.1k works in 2022–2025).
By volume, 2022–2025
- 1 China 1.3k works
- 2 United States 1.1k works
- 3 Japan 815 works
- 4 India 275 works
- 5 South Korea 220 works
- 6 Italy 216 works
- 7 Germany 171 works
- 8 United Kingdom 170 works
- 9 Spain 135 works
- 10 France 126 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Gastrointestinal Tumor Research and Treatment research?
By volume in 2022–2025, Sun Yat-sen University publishes the most Gastrointestinal Tumor Research and Treatment research, followed by The University of Texas MD Anderson Cancer Center and Chinese Academy of Medical Sciences & Peking Union Medical College.
By volume, 2022–2025
- 1 Sun Yat-sen UniversityChina 26 works
- 2 The University of Texas MD Anderson Cancer CenterUnited States 26 works
- 3 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 25 works
- 4 Sichuan UniversityChina 24 works
- 5 Fujian Medical UniversityChina 23 works
- 6 National Cancer Center Hospital EastJapan 20 works
- 7 Nanjing Medical UniversityChina 19 works
- 8 Cleveland ClinicUnited States 19 works
- 9 West China Hospital of Sichuan UniversityChina 18 works
- 10 Chinese PLA General HospitalChina 18 works
Who are the leading researchers in Gastrointestinal Tumor Research and Treatment?
The most-cited researchers publishing on Gastrointestinal Tumor Research and Treatment include Matthew Meyerson, Caroline Robert and Peter R. Galle.
- 1 Matthew Meyerson United States 4.2k citations
- 2 Caroline Robert France 3.3k citations
- 3 Peter R. Galle Germany 3.3k citations
- 4 Marc Ladanyi United States 3.1k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Gastrointestinal Tumor Research and Treatment research done?
The largest centres of Gastrointestinal Tumor Research and Treatment research in 2022–2025 are Tokyo (Japan), Beijing (China), Shanghai (China) and Seoul (South Korea). Among places with at least 20 works in it, it is an unusually large share of all research in Kashiwa.
Largest cities, 2022–2025
Where it is the local speciality
- KashiwaJP · 22.2 works43×
Location quotient: how much more of its research is in Gastrointestinal Tumor Research and Treatment than the world average.
Where is the best place to study Gastrointestinal Tumor Research and Treatment?
Among universities, judged by research, Fujian Medical University, Chinese Academy of Medical Sciences & Peking Union Medical College and Nanjing Medical University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Fujian Medical UniversityChina | 63.6 | 9.8% | 11.9× | 23 | +109.0% |
| 2 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 51.5 | 10.8% | 4.6× | 25 | +106.0% |
| 3 | Nanjing Medical UniversityChina | 48.5 | 11.8% | 6.8× | 19 | +17.0% |
| 4 | Hebei Medical UniversityChina | 46.5 | 13.1% | 8.3× | 10 | +87.8% |
| 5 | Soochow UniversityChina | 43.8 | 11.7% | 3.0× | 14 | +372.3% |
| 6 | Jichi Medical UniversityJapan | 43.5 | 9.0% | 21.0× | 10 | +21.1% |
| 7 | Sun Yat-sen UniversityChina | 43.3 | 11.9% | 3.0× | 26 | +1.2% |
| 8 | Sichuan UniversityChina | 42.7 | 11.9% | 2.6× | 24 | +42.2% |
| 9 | Keio UniversityJapan | 42.4 | 11.7% | 6.1× | 12 | +69.3% |
| 10 | Shandong First Medical UniversityChina | 40.7 | 14.7% | 6.5× | 9 | — |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Gastrointestinal Tumor Research and Treatment research growing?
Output in 2018–2022 was 14% higher than in 2013–2017, peaking in 2024. The fastest-growing topics are Gastrointestinal Tumor Research and Treatment.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.